FDA Clearance Tracker · P160017-S124
MiniMed 780G System
Last checked: Nov 20, 2026Latest source record: Aug 29, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Aug 29, 2025
Approved
Time to decision
126 days
Received Apr 25, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P160017-S124
- Device name
- MiniMed 780G System
- Applicant
- Medtronic Minimed, Inc.
- Applicant location
- Northridge, CA
- Received
- Apr 25, 2025
- Decided
- Aug 29, 2025
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P160017
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval of the MiniMed 780G System for expanding the indications for use to include type 2 diabetes mellitus in persons 18 years of age and older requiring insulin.
Source documents
Other decisions for Medtronic Minimed, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MiniMed Flex pump510(k)
K253743 · Decided Mar 12, 2026 · 108 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.